The effects of fasting on drug metabolism
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Introduction: There is considerable variability in the rates and extent of drug metabolism between patients due to physiological, genetic, pharmacologic, environmental and nutritional factors such as fasting. This variability in drug metabolism may result in treatment failure or, conversely, in increased side effects or toxicity. Preclinical studies have shown that fasting alters drug metabolism by modulating the activity of drug metabolizing enzymes involved. However, until recently little was known about the effects of fasting on drug metabolism in humans.Areas covered: This review describes the effects of fasting on drug metabolism based on both preclinical studies and studies performed in humans.Expert opinion: A better understanding of the effects of fasting may improve the efficacy and safety of pharmacotherapy for individual patients. Fasting contributes to variability in human drug metabolism by differentially affecting drug metabolizing enzymes. Although the effects of fasting on drug metabolism appear to be small (between 10-20%), fasting may be relevant for drugs with a small therapeutic range and/or in combination with other factors that contribute to variability in drug metabolism such as physiological, genetic or pharmacological factors. Therefore, additional research on this topic is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tobacco smoking [43], alcohol consumption [44], fasting [55], and concomitant drug use [56, 57] may influence antidepressant metabolization and thus the bioavailability of the drugs”
From The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review (2022) · cites this paper as [55]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169 · cited 2×
“introduced into drug substrates by oxidation, reduction or hydrolysis [8].”
BackgroundMartignoni, M., Groothuis, G. M. M., & de Kanter, R. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.875 · Cited by 1,478
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279 · cited 2×
“gastrointestinal tract, kidney and lungs [9].”
BackgroundWilliams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R., & Ball, S. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000794 · Cited by 928 · cited 3×
“UGTs represent the majority of phase II metabolizing enzymes.”
BackgroundBrandhorst, S., Choi, I. Y., Wei, M., Cheng, C. W., Sedrakyan, S., Navarrete, G., Dubeau, L., Yap, L. P., Park, R., Vinciguerra, M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.012 · Cited by 850 · cited 1×
“of oncology with low protein fasting mimicking diets to ease the burden of prolonged fasting [58,60].”
BackgroundNomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
Mackenzie, P. I., Walter Bock, K., Burchell, B., Guillemette, C., Ikushiro, S.-I., Iyanagi, T., Miners, J. O., Owens, I. S., & Nebert, D. W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000173483.13689.56 · Cited by 821 · cited 1×
“These enzymes represent two families (UGT1 and UGT2) including 9 human family UGT1 enzymes, 3 subfamily UGT2A and 8 UGT2B enzymes [13].”
BackgroundThe Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity
Watkins, R. E., Wisely, G. B., Moore, L. B., Collins, J. L., Lambert, M. H., Williams, S. P., Willson, T. M., Kliewer, S. A., & Redinbo, M. R. (2001) · Science · doi:10.1126/science.1060762 · Cited by 760 · cited 1×
“rifampicin), antimycotics, bile acids and many herbal compounds [33,34].”
BackgroundClinical pharmacokinetics and metabolism of irinotecan (CPT-11).
Mathijssen, R. H. J., van Alphen, R. J., Verweij, J., Loos, W. J., Nooter, K., Stoter, G., & Sparreboom, A. (2001) · PubMed · Cited by 740
McGill, M. R., & Jaeschke, H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1007-6 · Cited by 704 · cited 1×
“UGT1A1 is also involved in acetaminophen (paracetamol) metabolism [15].”
BackgroundOverview of Therapeutic Drug Monitoring
Kang, J.-S., & Lee, M.-H. (2009) · The Korean journal of internal medicine · doi:10.3904/kjim.2009.24.1.1 · Cited by 669 · cited 1×
“levels within an established therapeutic range [64].”
Research works printed but not linked: 6
- Berg JMTJ, 2002, Biochemistry
- Pratt V, 2012, Medical genetics summaries [Internet]
- Kato R, 1965, J Pharmacol Exp Ther, 150, 285
- Klein S, 1993, Am J Physiol, 265, E801
- Abbasi J, 2017, JAMA
- Mathijssen RH, 2001, Clin Cancer Res, 7, 2182
Cited by
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Rahman, M. M., Islam, F., -Or-Rashid, M. H., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903570 · Cited by 253
“Individual therapeutic responses and drug-related side effects differ based on various factors such as gender, age, BMI, disease state, environmental factors, and genetic polymorphisms (Lammers et al., 2020).”
BackgroundA cross-talk between gut microbiome, salt and hypertension
Naqvi, S., Asar, T. O., Kumar, V., Al-Abbasi, F. A., Alhayyani, S., Kamal, M. A., & Anwar, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111156 · Cited by 99
Sørensen, A., Ruhé, H. G., & Munkholm, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01285-w · Cited by 65
Veldscholte, K., Cramer, A. B. G., Joosten, K., & Verbruggen, S. C. A. T. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.07.030 · Cited by 20
“Additionally, fasting might contribute to variability in drug metabolism, and thus drug levels, by its effects on metabolizing enzyme activity [158].”
Hasan, M. S. A., Bhuia, M. S., Chowdhury, R., Husain, Z., Saifuzzaman, M., Mia, E., Akbor, M. S., Yana, N. T., Islam, M. A., Ansari, S. A., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.004 · Cited by 21
Metadata
- Authors
- Lammers, L. A., Achterbergh, R., Mathôt, R. A. A., & Romijn, J. A.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Lammers, Laureen A.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2019-12-24
- Volume
- 16
- Issue
- 1
- Pages
- 79-85
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2994971940
- Cited by
- 32
- References
- 61
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 6 · 2022: 10 · 2021: 7
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Expert Opinion on Drug Metabolism & Toxicology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- fasting, drug metabolism, interindividual variability, drug-metabolizing enzymes, pharmacokinetics, drug therapy safety, therapeutic window, dietary factors
- MeSH terms
- Animals, Pharmaceutical Preparations, Fasting, Humans, Treatment Outcome, Treatment Failure, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of fasting on drug metabolism. https://app.cochat.ai/papers/10.1080/17425255.2020.1706728
- The paper
- Lammers, L. A., Achterbergh, R., Mathôt, R. A. A., & Romijn, J. A. (2020). The effects of fasting on drug metabolism. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2020.1706728
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



